サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655343

マラリア診断の世界市場

Malaria Diagnostics

出版日
ページ情報
英文 162 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
マラリア診断の世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 162 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マラリア診断の世界市場は2030年までに13億米ドルに達する見込み

2024年に9億170万米ドルと推定されるマラリア診断の世界市場は、分析期間2024-2030年にCAGR 5.6%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである迅速診断検査は、CAGR 5.7％を記録し、分析期間終了時には6億8,590万米ドルに達すると予測されます。顕微鏡診断セグメントの成長率は、分析期間中CAGR 4.9%と推定されます。

米国市場は2億3,330万米ドルと推定、中国はCAGR 8.6％で成長予測

米国のマラリア診断市場は、2024年には2億3,330万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億9,000万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と4.5％と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界のマラリア診断市場- 主要動向と促進要因のまとめ

マラリア診断はこの風土病との闘いでどのように進化しているのか？

マラリア診断は、特にサハラ以南のアフリカや東南アジアなどの地域で、最も蔓延している寄生虫性疾患との世界の闘いにおいて極めて重要です。マラリアを効果的に治療し、重篤な合併症や死亡を防ぐためには、正確かつ早期に発見することが不可欠です。顕微鏡検査や迅速診断検査（RDT）のような伝統的な診断方法は、長い間、マラリア診断のゴールドスタンダードでした。しかし、診断技術の進歩により、これらの検査の精度、スピード、利用しやすさが向上しています。ポリメラーゼ連鎖反応（PCR）検査などの新しい分子診断ツールは感度が向上しており、従来の方法では見逃されがちな低レベルの寄生虫を検出することができます。診断技術の進化は、マラリアを撲滅し、患者の予後を改善するための世界の努力を続ける上で不可欠です。

どのような技術革新がマラリア診断を変革しているのか？

技術革新はマラリア診断を大きく進歩させ、その精度とアクセシビリティを向上させています。最も注目すべき開発の一つは、ポータブル分子検査装置のイントロダクションであり、これにより遠隔地や資源が限られた環境でも高精度の検出が可能になった。LAMP法（loop-mediated isothermal amplification：ループ媒介等温増幅法）などの技術を用いたこれらの検査機器は、大規模な検査インフラを必要とすることなく、迅速に結果を得ることができます。さらに、デジタル顕微鏡の進歩により、寄生虫の自動検出が可能になり、人為的ミスが減り、診断ワークフローの効率が向上しています。AIと機械学習の診断への統合により、検査結果の解釈はさらに改善され、臨床医がマラリア治療に関してより迅速で信頼性の高い判断を下せるようになりました。

資源が限られた地域でマラリア診断が直面する課題とは？

マラリア診断の進歩にもかかわらず、資源が限られた地域でこれらのツールを展開するには、いくつかの課題があります。大きな問題の一つは、先進的な診断法のコストと複雑さであり、マラリアが最も蔓延している遠隔地での利用を制限する可能性があります。顕微鏡検査やRDTのような伝統的な方法は、費用対効果は高いもの、熟練した人材を必要とし、依然として低レベルの感染を見逃す可能性があります。もう一つの課題は、診断材料のサプライチェーンを維持し、アウトブレイク時に手の届きにくい地域でも検査が受けられるようにすることです。さらに、地域によって診断の質にばらつきがあるため、訓練や設備が一定しておらず、信頼性の高いマラリア診断への普遍的なアクセスを達成する努力を妨げています。このような障壁に対処することは、マラリア管理を改善し、最終的に流行地域の疾病負担を軽減するために極めて重要です。

マラリア診断市場の成長はいくつかの要因によってもたらされる

マラリア診断市場の成長は、流行地域におけるマラリアの有病率の増加、診断技術の進歩、マラリア撲滅に向けた世界の取り組みなど、いくつかの要因によってもたらされます。携帯型分子診断やAI駆動ツールなどの技術革新により、ヘルスケアインフラが限られた地域でも正確でタイムリーな診断へのアクセスが拡大しています。マラリア撲滅を目的とした政府・非政府組織からの資金提供の増加も、改善された診断方法の採用を加速させています。さらに、マラリアの重症化や死亡を防ぐためには早期発見が重要であるとの認識が高まり、より信頼性が高く効率的な検査ソリューションへの需要が高まっています。これらの要因と継続的な研究開発努力が相まって、マラリア診断市場の継続的な成長が見込まれています。

セグメント

セグメント（迅速診断検査、顕微鏡診断、分子診断）

調査対象企業の例（注目の16社）

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP13150

Global Malaria Diagnostics Market to Reach US$1.3 Billion by 2030

The global market for Malaria Diagnostics estimated at US$901.7 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the analysis period. Growth in the Microscopic Diagnostics segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$233.3 Million While China is Forecast to Grow at 8.6% CAGR

The Malaria Diagnostics market in the U.S. is estimated at US$233.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$290.0 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Malaria Diagnostics Market - Key Trends & Drivers Summarized

How Are Malaria Diagnostics Evolving in the Fight Against This Endemic Disease?

Malaria diagnostics are crucial in the global fight against one of the most prevalent parasitic diseases, particularly in regions like sub-Saharan Africa and Southeast Asia. Accurate and early detection of malaria is essential to effectively treating the disease and preventing severe complications or death. Traditional diagnostic methods like microscopy and rapid diagnostic tests (RDTs) have long been the gold standard in malaria diagnosis. However, advances in diagnostic technologies are improving the accuracy, speed, and accessibility of these tests. New molecular diagnostic tools, such as polymerase chain reaction (PCR) testing, have enhanced sensitivity and can detect low parasite levels that are often missed by conventional methods. The evolution of diagnostic techniques is vital in the ongoing global efforts to eliminate malaria and improve patient outcomes.

What Technological Innovations Are Transforming Malaria Diagnostics?

Technological innovations are driving significant advancements in malaria diagnostics, improving their accuracy and accessibility. One of the most notable developments is the introduction of portable molecular testing devices, which allow for highly accurate detection in remote or resource-limited settings. These devices, which use techniques like loop-mediated isothermal amplification (LAMP), can provide results quickly without requiring extensive laboratory infrastructure. Additionally, advancements in digital microscopy have enabled automated parasite detection, reducing human error and increasing the efficiency of diagnostic workflows. The integration of AI and machine learning in diagnostics has further improved the interpretation of test results, helping clinicians make faster and more reliable decisions regarding malaria treatment.

What Are the Challenges Facing Malaria Diagnostics in Resource-Limited Areas?

Despite the progress in malaria diagnostics, there are several challenges in deploying these tools in resource-limited areas. One major issue is the cost and complexity of advanced diagnostic methods, which can limit their availability in remote regions where malaria is most prevalent. Traditional methods like microscopy and RDTs, while cost-effective, require skilled personnel and can still miss low-level infections. Another challenge is maintaining the supply chain for diagnostic materials and ensuring that tests are available in hard-to-reach areas during outbreaks. Additionally, the variability in diagnostic quality across regions, driven by inconsistent training and equipment, hinders efforts to achieve universal access to reliable malaria diagnostics. Addressing these barriers is critical for improving malaria management and ultimately reducing the disease burden in endemic areas.

Growth in the Malaria Diagnostics Market Is Driven by Several Factors

The growth in the malaria diagnostics market is driven by several factors, including the increasing prevalence of malaria in endemic regions, advancements in diagnostic technologies, and global efforts toward malaria elimination. Technological innovations such as portable molecular diagnostics and AI-driven tools are expanding access to accurate and timely diagnostics in areas with limited healthcare infrastructure. The rise in funding from governmental and non-governmental organizations aimed at combating malaria is also accelerating the adoption of improved diagnostic methods. Furthermore, the growing awareness of the importance of early detection in preventing severe malaria cases and fatalities is pushing demand for more reliable and efficient testing solutions. These factors, combined with ongoing R&D efforts, are expected to drive continued growth in the malaria diagnostics market.

SCOPE OF STUDY:

The report analyzes the Malaria Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Rapid Diagnostic Tests, Microscopic Diagnostics, Molecular Diagnostics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Malaria Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Malaria Drives Growth in Malaria Diagnostics Market
    • Technological Advancements in Rapid Diagnostic Tests Propel Adoption in Malaria-endemic Regions
    • Increased Focus on Early Detection Strengthens Business Case for Advanced Diagnostic Solutions
    • Emergence of Point-of-care Diagnostics Spurs Growth in Remote and Low-resource Settings
    • Rising Availability of Multiplex Diagnostic Platforms Propels Adoption of Comprehensive Testing
    • Increasing Global Health Initiatives to Combat Malaria Expand Market for Diagnostic Tools
    • Advancements in Molecular Diagnostics Strengthen Business Case for Accurate Malaria Detection
    • Rising Need for Accurate Surveillance Tools Accelerates Demand for Innovative Diagnostics
    • Growing Focus on Precision Medicine Generates Demand for Genotype-specific Malaria Diagnostics
    • Improved Diagnostic Technologies Propel Growth in Drug Resistance Testing for Malaria
    • Increasing Prevalence of Multi-drug-resistant Malaria Strains Drives Need for Advanced Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Malaria Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Rapid Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Microscopic Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • JAPAN
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CHINA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • EUROPE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • FRANCE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • GERMANY
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • INDIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AFRICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030

IV. COMPETITION